Pure Global

Model to Predict Coinfection in Elderly Patients With COVID-19 - Trial NCT06321367

Access comprehensive clinical trial information for NCT06321367 through Pure Global AI's free database. This phase not specified trial is sponsored by Xiangya Hospital of Central South University and is currently Completed. The study focuses on Covid19. Target enrollment is 1000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06321367
Completed
Trial Details
ClinicalTrials.gov โ€ข NCT06321367
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Model to Predict Coinfection in Elderly Patients With COVID-19
Construction and Validation of a Predictive Model of Coinfections in Elderly COVID-19 Patients After Abandoning Zero Policy

Study Focus

Covid19

Observational

Sponsor & Location

Xiangya Hospital of Central South University

Changsha, China

Timeline & Enrollment

N/A

Dec 20, 2022

Jun 30, 2023

1000 participants

Primary Outcome

Coinfection

Summary

The goal of this observational study is to learn about the clinical characteristics and
 construction of a predictive model in elderly COVID-19 patients. The main question it aims to
 answer is the main clinical characteristics and risk factors of elderly COVID-19 patients.
 Participants will not be asked to do any other intervening measure.

ICD-10 Classifications

COVID-19, virus identified
COVID-19, virus not identified
Coronavirus infection, unspecified site
Rift Valley fever
Plague

Data Source

ClinicalTrials.gov

NCT06321367

Non-Device Trial